Toronto Dominion Bank Imv Inc. Transaction History

Toronto Dominion Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	BUY	$0.47 - $0.75 $3,393 - $5,415	7,221 Added 384.3%	9,100 $5,000
Q2 2022 Aug 11, 2022	BUY	$0.56 - $1.45 $842 - $2,180	1,504 Added 401.07%	1,879 $1,000
Q1 2022 May 09, 2022	SELL	$1.07 - $1.5 $13,401 - $18,787	-12,525 Reduced 97.09%	375 $0
Q4 2021 Feb 04, 2022	BUY	$1.22 - $1.78 $15,515 - $22,638	12,718 Added 6987.91%	12,900 $16,000
Q3 2021 Nov 08, 2021	BUY	$1.35 - $2.16 $245 - $393	182 New	182 $0

Ticker IMV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,452,200
Description
IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is P...

Get notified when there are updates to the investment portfolio of Toronto Dominion Bank, based on Form 13F filings with the SEC.

Stay updated on Toronto Dominion Bank with notifications on news.